Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicine for treating myasthenia gravis

A technology of myasthenia gravis and traditional Chinese medicine, which is applied in drug combinations, medical formulas, muscular system diseases, etc., can solve problems such as inability to achieve a radical cure, and achieve remarkable and definite curative effects

Inactive Publication Date: 2005-10-12
王振球
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, Western medicine mainly uses brobistigmine or hormone drugs for symptomatic treatment of myasthenia gravis, which can temporarily relieve symptoms, but cannot achieve the goal of radical cure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] A kind of Chinese medicine for treating myasthenia gravis is made up of the Chinese medicine of following prescription:

[0020] Pick:

[0021] Codonopsis 15g Poria cocos 15g Atractylodes macrocephala 15g

[0022] Yam 15g Pueraria 5g Rehmannia glutinosa 15g

[0023] Eucommia 15g, antler 2g, medlar 15g

[0024] Rhizoma Cyperi 10g Astragalus 15g Cornus officinalis 10g

[0025] Bupleurum 5g Angelica 15g Sangjisi 15g

[0026] Cimicifuga 5g Achyranthes bidentata 15g Polygonum multiflorum 15g

[0027] Dendrobium 10g Fangfeng 5g

[0028] From the traditional Chinese medicine of the above prescription, the decoction is prepared through conventional Chinese medicine processing technology.

[0029] Clinical Observation Report on 34 Cases of Myasthenia Gravis Treated with the Above-mentioned Decoction

[0030] Key words: myasthenia gravis traditional Chinese medicine decoction

[0031] Abstract: Objective: To understand the clinical effect of traditional Chinese medicine i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine in the form of pill, powder, or decoction for treating myasthenia gravis is prepared from 19 Chinese-medicinal materials including pilose antler, wolfberry fruit, astragalus root, Chinese angelica root, etc through conventional process.

Description

technical field [0001] The invention belongs to traditional Chinese medicine, more precisely, it is a traditional Chinese medicine for treating myasthenia gravis. Background technique [0002] Myasthenia gravis is a disease with no clear cause so far. The main symptoms are ptosis, diplopia, slurred speech, difficulty in chewing and swallowing, difficulty in raising the head, and difficulty in breathing in severe cases. It is generally believed to be due to transmission dysfunction at the neuromuscular junction, or it is believed to be due to autoimmune dysfunction. At present, Western medicine mainly adopts brobistigmine or hormone drugs for symptomatic treatment of myasthenia gravis, which can temporarily relieve symptoms, but cannot achieve the purpose of radical cure. Contents of the invention [0003] In view of this, the purpose of the present invention is to provide a kind of Chinese medicine that can treat myasthenia gravis. [0004] The object of the present inve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61P21/04
Inventor 王振球王沛王迪
Owner 王振球
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products